These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 392136)

  • 1. [Angiotensin converting enzyme--captopril].
    Kaneko Y; Shionoiri H; Uneda S; Fujishima S
    Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
    [No Abstract]   [Full Text] [Related]  

  • 2. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of captopril in arterial hypertension with a stable and malignant course].
    Lordkipanidze NL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on arterial blood pressure].
    Watanabe H
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):405-19. PubMed ID: 6750185
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertensive crisis with captopril].
    Almeida FA; Ribeiro AB; Marson O; Kohlmann O; Alves Filho G; Saragoça MA; Ramos OL
    Arq Bras Cardiol; 1981 Nov; 37(5):425-9. PubMed ID: 7052030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Captopril (oral inhibitor of angiotensin I converting-enzyme) in arterial hypertension].
    Simonetti BM; Manzi M; Feriozzi S; Pierucci A
    Clin Ter; 1982 Jul; 102(1):67-83. PubMed ID: 6754215
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antihypertensive effect of an oral angiotensin I-converting enzyme inhibitor in two cases with malignant hypertension (author's transl)].
    Mizuno K; Gotho M; Tsutsui K; Yamazaki M; Shigetomi S; Kudo S; Matsui J; Haruyama K; Nakamura I; Toki T; Nagasawa S; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1981 Jan; 23(1):1-12. PubMed ID: 7026848
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
    Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
    Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Captopril].
    Belovezhov N
    Vutr Boles; 1981; 20(6):30-4. PubMed ID: 7039126
    [No Abstract]   [Full Text] [Related]  

  • 11. First dose effect of the oral angiotensin converting enzyme inhibitor captopril.
    Fagard R; Amery A; Lijnen P; Staessen J
    Arch Int Pharmacodyn Ther; 1980; Suppl():178-87. PubMed ID: 6251761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril on the development of tolerance to guanethidine.
    Rankin GO; Haas GJ
    Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progressive reversible kidney insufficiency after blood pressure reduction with captopril].
    Kindler J; Konrads A; Meurer KA; Sieberth HG
    Internist (Berl); 1981 Jun; 22(6):360-3. PubMed ID: 6265394
    [No Abstract]   [Full Text] [Related]  

  • 15. [Captopril - profile of a new antihypertensive (author's transl)].
    Gross F
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme].
    Waeber B; Gavras H; Brunner HR; Chappuis P; Turini GA
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1981-3. PubMed ID: 219469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of orally active angiotensin I converting enzyme inhibitor (SQ 14,225) in the treatment of malignant hypertension.
    Abe I; Kawasaki T; Ueno M; Kawano Y; Uezono K; Ogata M; Kawazoe N; Omae T; Fukiyama K
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):157-66. PubMed ID: 6247259
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
    Walter NM; Whitworth JA; Kincaid-Smith P
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
    Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.